Time to Next Treatment as a Meaningful Endpoint for Trials of Primary Cutaneous Lymphoma
Sign Up to like & getrecommendations! Published in 2020 at "Cancers"
DOI: 10.3390/cancers12082311
Abstract: Time to next treatment (TTNT) is an emerging endpoint in clinical studies of primary cutaneous T-cell lymphomas (CTCL), with utility as a surrogate marker for the “duration of clinical benefit”. TTNT provides a highly clinically… read more here.
Keywords: endpoint; time next; next treatment; treatment ... See more keywords